65,437 trials
Intimate Partner Violence
Primary: Alcohol and Substance Use: Timeline Follow-back (TLFB)-Modified Computer Version — 0.54; 0.66; 0.12; 0.29 % days of drug use or heavy drinking — p=0.560
Bacterial Infection · Benign Neoplasm · Malignant Neoplasm
Primary: Central Line-associated Bloodstream Infections (CLABSI) Events During the At-risk Days — 5.44; 3.1 CLABSI per 1000 at-risk days.
Type 1 Diabetes
Primary: Efficacy Assessed by Median of HbA1c, — 60 mmol/mol
Lower Extremity or Diabetic Foot Ulcers · Bacterial Infection
Primary: Total Bacteria Colony Forming Units (CFUs; Natural-log Transformed), With Tryptic Soy Agar (TSA) Plating — 9.6561; 9.6880; 11.9611; 9.1547 Natural Log Transformed…
Dry Eye
Primary: Tolerability: The Primary Tolerability Endpoint is the Test Substance Tolerance (Visual Analog Scale) at 8 Weeks (56 Days) — 100; 100 score on a scale — p=1.000
Cerebrovascular Accident
Primary: Box and Block Test — 21; 33; 12; 7 blocks
Cataract
Primary: Monocular Photopic Distance Corrected Intermediate Visual Acuity (DCIVA) at 66 Centimeters (cm) — 0.175; 0.313 logMAR — p=<0.001
Learning Disability
Primary: Falls — 3 Falls
Fibromyalgia
Primary: Pitsburgh Sleep Quality Index — 8.3 score on a questionnarie
Post Menopausal Breast Cancer
Primary: Summary of Number of Participants With Treatment Emergent Adverse Events (TEAE) - All Grades — 4; 0; 4; 195 Participants
Aging
Primary: Geriatric Depression Scale Change Score — .89; 0.50 score on a scale
Osteoarthritis, Knee
Primary: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) — -4.85; 0.26; -3.97; -2.53 units on a scale — p=0.0003
Chemotherapy-induced Nausea and Vomiting
Primary: Patient Outcomes — 15; 15; 0 Participants
Cancer of Prostate · Cancer of the Prostate · Prostate Cancer
Primary: Cancer-specific Quality of Life — 44.7; 42.0; 35.9; 52.1 score on a scale
Medical Abortion · Pain
Primary: Maximum Self-reported Pain Score on a Numeric Rating Scale — 7; 7 score on a scale